This is why at Real Peptides, we are relentless about our small-batch synthesis process
Our clinic follows strict safety protocols and uses cutting-edge technology for a smooth, hassle-free experience
Two oral non peptidics small molecule GLP-1RA have completed phase 2 trials for weight management and T2D: Once-daily Orforglipron (LY3502970) and twice daily Danuglipron (PF-06882961)
Free to start
The advantages of PRRT include its selectiveness in delivering radionuclides, which reduces systemic side effects, and its effective control of advanced, inoperable or metastatic tumors
Os resultados descritos podem variar de pessoa para pessoa, pois devem ser consideradas as caractersticas individuais como: existncia de outras patologias, alimentao, atividades fsicas, bem como o uso correto descrito na posologia.